What is NDC 72266-139?

72266-139 is the product NDC for Bimatoprost, Bimatoprost .3 mg/mL solution/ drops, listed with the FDA by Fosun Pharma USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Fosun Pharma USA Inc., NDC labeler code 72266. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bimatoprost?

23 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bimatoprost NDC 72266-139 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72266-139Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72266-0139Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72266-139-01	7226601390172266013901	1 BOTTLE in 1 CARTON (72266-139-01) / 2.5 mL in 1 BOTTLEMarketed from Aug 10, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bimatoprost
Generic name (nonproprietary): bimatoprost
Active ingredients: Bimatoprost — .3 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Fosun Pharma USA Inc.NDC labeler code 72266
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210126
Marketing start: Aug 10, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Prostaglandins (Chemical structure)
Identifiers: Product ID 72266-139_2c7970dc-8873-7e74-e063-6294a90a397fSPL ID 2c7970dc-8873-7e74-e063-6294a90a397fSPL set ID 2f9ee30a-1737-44b2-8479-79a3ee88bf5bRxCUI 308739UNII QXS94885MZ
Pharmacologic class: Prostaglandin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472266013901 followed by a unit qualifier and the quantity

Package 72266-0139-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 9, 2022.

Indications (excerpt from the label)

Bimatoprost ophthalmic solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. Bimatoprost ophthalmic solution, 0.03% is a prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72266-139

What is NDC 72266-139?: 72266-139 is the product NDC for Bimatoprost, Bimatoprost .3 mg/mL solution/ drops, listed with the FDA by Fosun Pharma USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bimatoprost.
What is the active ingredient?: Bimatoprost.
Who is the labeler?: Fosun Pharma USA Inc., NDC labeler code 72266. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bimatoprost?: 23 other product NDCs are listed under this name. See all Bimatoprost NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Bimatoprost NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Bimatoprost	Bimatoprost .1 mg/mL	Solution/ dropsOphthalmic	First Nation Group, LLC	81469-291	81469-0291-0581469-0291-25
Bimatoprost	Bimatoprost .1 mg/mL	Solution/ dropsOphthalmic	Lifestar Pharma LLC	70756-626	70756-0626-30
Bimatoprost	Bimatoprost .1 mg/mL	Solution/ dropsOphthalmic	Lifestar Pharma LLC	70756-627	70756-0627-30
Bimatoprost	Bimatoprost .1 mg/mL	Solution/ dropsOphthalmic	Lifestar Pharma LLC	70756-628	70756-0628-30
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	Fosun Pharma USA Inc.	72266-241	72266-0241-01
Bimatoprost	Bimatoprost .1 mg/mL	Solution/ dropsOphthalmic	Amneal Pharmaceuticals NY LLC	60219-2149	60219-2149-0160219-2149-0260219-2149-04
bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	Alembic Pharmaceuticals Limited	46708-511	46708-0511-0346708-0511-05
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	Aurobindo Pharma Limited	65862-802	65862-0802-0565862-0802-1065862-0802-44
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	Micro Labs Limited	42571-128	42571-0128-2142571-0128-2842571-0128-35
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	NuCare Pharmaceuticals,Inc.	68071-3612	68071-3612-05

All 24 Bimatoprost NDCs

Other NDCs under ANDA 210126

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210126
Product	Strength	Form · route	Labeler	Product NDC
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	NuCare Pharmaceuticals,Inc.	68071-3590
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	Gland Pharma Limited	68083-296
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	Gland Pharma Limited	68083-295
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	Fosun Pharma USA Inc.	72266-140
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	Fosun Pharma USA Inc.	72266-241
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	Gland Pharma Limited	68083-439